Ronald Peck
Geen lopende functies
Vermogen: 439 935 $ op 30-04-2024
Profiel
Ronald Peck bekleedt de functie van Chief Medical Officer bij Arvinas, Inc. In het verleden bekleedde Dr. Peck de functie van Vice President-Yervoy Global Development Lead bij Bristol Myers Squibb Co, Chief Medical Officer voor Kolltan Pharmaceuticals, Inc, Senior Vice President-Clinical Research bij Tesaro, Inc en assistent professor aan de Universiteit van Virginia. Dr. Peck behaalde een doctoraal aan de Georgetown University en een doctoraat aan het Sidney Kimmel Medical College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARVINAS, INC.
0.02% | 31-03-2024 | 13 922 ( 0.02% ) | 439 935 $ | 30-04-2024 |
Eerdere bekende functies van Ronald Peck
| Bedrijven | Functie | Einde |
|---|---|---|
| ARVINAS, INC. | Hoofd Techniek/Wetenschap/O&O | 18-03-2024 |
| TESARO INC | Hoofd Techniek/Wetenschap/O&O | 01-07-2019 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Hoofd Techniek/Wetenschap/O&O | 01-12-2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-05-2015 |
| University of Virginia | Corporate Officer/Principal | 01-02-2000 |
Opleiding van Ronald Peck
| Georgetown University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
